Bangalore (Karnataka) [India], November 24 (ANI/PRNewswire): Symbio Generrics India Private Limited (Symbio), a specialized Active Pharmaceutical Ingredients (API) & Intermediates manufacturing and marketing organization, announced today that it has completed an equity capital raise from Ascent Capital, a leading growth-capital focused private equity fund. Symbio was founded by pharmaceutical professionals, Salim Shaikh and Abhijit Kale. They were soon joined by the third promoter, Akash Puranik; all of whom possess decades of experience in the global pharmaceutical industry. Symbio's journey from a sales and marketing organization to a full-fledged vertically integrated manufacturer of specialized APIs has been exemplary. Through a well-developed customer ecosystem, the highly experienced & skilled team at Symbio has established a global footprint for its APIs. Ascent Capital's sizeable investment in Symbio will further accelerate the company's expansion plans and
Go
Your browser has Javascript disabled, so some things may not quite work how they should on LI right now: please enable JavaScript in your browser to fix things, we have no nefarious trackers, or scripts by Facebook, Google or others.
In Brief
Friday, 21 May 2021 22:18 Private equity / VC
Krishitantra, a soil-tech platform, has raised $1 million (Rs 7.6 crore) in its seed round of funding from agritech-focused venture capital investor Omnivore and Nabventures. Nabventures is anchored by Nabard (National Bank for Agriculture and Rural Development). It has other investors as well. The startup will primarily use the funding to fuel its local and foreign expansion.